Improving Fertility Through Science

Investor Relations

Investor Relations

Corporate Profile

OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility. The Company’s patented technology is based on the discovery of egg precursor cells (EggPCSM), which are found in the ovaries. By applying proprietary technology to identify and purify EggPCs, AUGMENTSM aims to improve egg quality and increase the success of in vitro fertilization (IVF). OvaScience’s team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.

OVAS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$9.21
Change (%) Stock is Up 0.05 (0.55%)
Volume34,962
Data as of 07/23/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More »
DateTitle 
06/23/14OvaScience to Present at the 2014 BIO International Convention
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 23, 2014-- OvaScienceSM, (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 2014 BIO International Convention on Tuesday, June 24, 2014 at 3:00 pm PT at the San Diego Convention Center. The BIO International Con... 
Printer Friendly Version
06/18/14OvaScience to Present at the JMP Securities Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 18, 2014-- OvaScienceSM, (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Arthur Tzianabos, Ph.D., Chief Scientific Officer of OvaScience, will present at the JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 11:30 am ET in The Westin New York Grand Central. A live audio webca... 
Printer Friendly Version
05/27/14OvaScience to Present at the Jefferies 2014 Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 27, 2014-- OvaScienceSM, (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that the Company's management team will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, at 8:00am EDT in the Grand Hyatt, New York. A live audio webcast of the presentation can be accessed by visi... 
Printer Friendly Version
05/08/14OvaScience Reports First Quarter 2014 Financial Results
-- Company Commenced International Launch of AUGMENTSM -- CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 8, 2014-- OvaScienceSM, (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported first quarter 2014 financial results, and highlighted recent accomplishments. “We are on track with the international launch of our first fertility treatment, AU... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.